Solid Biosciences Inc. SLDB Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Solid Biosciences Inc.’s reported figures.
Based on the most recent quarter.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s cash ratio?
- Solid Biosciences Inc. (SLDB) reported cash ratio of 9.8× in Q1 2026.
- How has Solid Biosciences Inc.'s cash ratio changed year-over-year?
- Solid Biosciences Inc.'s cash ratio increased by 34.0% year-over-year, from 7.3× to 9.8×.
- What is the long-term trend for Solid Biosciences Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s cash ratio has grown at a -22.3% compound annual growth rate (CAGR), from 6.3× to 1.8×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.